Expression of interleukin-2 (IL-2) receptor α and CD45RO antigen on T- lymphocytes cultured with measles virus antigens, compared with humoral immunity in measles vaccinees

Vaccine

Volumn 17, Issue 11-12, 1999, Pages 1369-1375

  Toyoda, Mika ^a   Ihara, Toshiaki ^a   Nakano, Takashi ^a   Ito, Masahiro ^b   Kamiya, Hitoshi ^a  

^a MIE NATIONAL HOSPITAL   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell mediated immunity; Measles; Vaccine

Indexed keywords

CD45 ANTIGEN; INTERLEUKIN 2 RECEPTOR; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; VIRUS ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; HUMAN CELL; MALE; MEASLES VACCINATION; MEASLES VIRUS; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SEROLOGY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY;

ADOLESCENT; ADULT; ANTIBODY FORMATION; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, VIRAL; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MEASLES VACCINE; MEASLES VIRUS; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; RECEPTORS, INTERLEUKIN-2; RUBELLA VACCINE; T-LYMPHOCYTES; VACCINES, COMBINED;

EID: 0033577264     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00403-4     Document Type: Article

References (18)

1. Cherry J.D., Carney J.M., Naiditch M.J., O'Connor K. Measles-specific lymphocyte reactivity and serum antibody in subjects with different measles histories. Am J Dis Child. 134:1980;567-571.
2. Panum P.L. Observations made During the Epidemic of Measles on Faroe Islands in the Year 1846. New York: American Publishing Association, 1940.
3. Edmonston M.B., Addis D.G., MePherson J.T., Berg J.L., Circo S.R., Davis J.P. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA. 263:1990;2467-2471.
4. Zhuji Measles vaccine Study Group Epidemiological examination of immunity period of measles vaccine. Clin Med J. 67:1987;19-22.
5. Mathias R., Meekison J., Arcand T., Schechter M. The role of secondary vaccine failures in measles outbreaks. Am J Public Health. 79:1989;475-478.
6. Markowitz L.E., Preblud S.R., Fine P.E.M., Orenstein W.A. Duration of live measles vaccine-induced immunity. Pediat Infect Dis J. 2:1990;101-110.
7. Chen R, Mofenson L, Albrecht P, Page P, Orenstein W, Etkind P. Protective measles antibody titers in college students. Paper presented at the 35th EIS Conference, Atlanta, GA, April 14-18, 1986.
8. Kobune R., Sakata H., Sugiura A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol. 64:1990;700-705.
9. Ito M., Nakano T., Kamiya T., Kitamura K., Komada Y., Ihara T., Kamiya H., Sakurai M. Activation of lymphocytes by varicella-zoster virus: expression of interleukin-2 receptors on lymphocytes cultured with varicella-zoster virus antigen. J Inf Dis. 165:1992;158-161.
10. Nakano T., Ito M., Mizuno T., Mizutani K., Ihara T., Kamiya H., Sakurai M. Increase of receptor and CD45RO antigen on lymphocytes cultured with human cytomegalovirus. Cell Immnol. 147:1993;73-80.
11. Tamin A., Rota P.A., de Wang Z., Health J.L., Anderson L.J., Bellini W.J. Antigenic analysis of current wild type and vaccine strains of measles virus. J Infect Dis. 170:1994;795-801.
12. Rota J.S., Health J.L., Rota P.A., King G.E., Celma M.L., Carabana J., Fernandez-Munos R., Brown D., Jin L., Bellini W. Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J Infect Dis. 173:1996;32-37.
13. Yamaguti S. Identification of three lineages of wild measles virus by nucleotide sequence analysis of N, P, M, F and L genes in Japan. J Med Virol. 52:1997;113-120.
14. Clements CJ, Cutts FT. The epidemiology of measles: 30 years of vaccination. In: ter Meulen V, Billeter MA, editors. Measles virus-current topics in microbiology and immunology, vol. 191. Berlin: Springer-Verlag, 1995. p. 13-33.
15. Guris D., Mccready J., Watson J.C., Atkinson W.L., Health J.L., Bellini W.J., Polloi A. Measles vaccine effectiveness and during of vaccine-induced immunity in the absence of boosting from exposure to measles virus. Pediatr Infect Dis J. 15:1996;1082-1086.
16. Xian J., Chen Z. Measles vaccine in the People's Republic of China. Rev Infect Dis. 5:1983;506-510.
17. Wu V.H., Mcfarand H., Mayo K., Hanger L., Griffen D.E., Dhib-Jalbut S. Measles virus-specific cellular immunity in patients with vaccine failure. J Clin Microviol. 31:1993;118-122.
18. Takahashi M. The present condition of MMR vaccination. Jpn J Ped. 43:1990;751-758.